News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2025.03.18
Report on participation in BIO International Convention 2024 San Diego
-
2025.03.18
Announcement of the 22nd Ordinary General Meeting of Shareholders
-
2025.03.18
Announcement of Presentation at the 18th Annual Meeting of the Japanese Society for Molecular Imaging
-
2025.03.18
Announcement of a lecture by our CEO, Tohru Mizushima, at Fujita Health University
-
2025.03.18
Announcement of the start of the new grant (PC-SOD Grant)
-
2025.03.18
Announcement of the Establishment of a Donation-Funded Chair at the Faculty of Pharmaceutical Sciences, Sojo University, and the Appointment of the Company’s CEO as a Specially Appointed Professor
-
2025.03.18
Announcement of the Conclusion of a Joint Research Agreement with Mie University
-
2023.12.25
Announcement of Preliminary Results of Phase II Clinical Trial of PC-SOD
-
2023.12.21
Semi-annual report for the 22nd period has been submitted
-
2023.12.12
Announcement of Phase III Clinical Trial Results for LT-5001